Targeting Liposomal Chemotherapy via Both Tumor Cell-Specific and Tumor Vasculature-Specific Ligands Potentiates Therapeutic Efficacy

Cancer Research - United States
doi 10.1158/0008-5472.can-06-2117
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Tumor Targeting via Integrin Ligands

Frontiers in Oncology
Cancer ResearchOncology
2013English

Structural and Energetic Evidence for Highly Peptide-Specific Tumor Antigen Targeting via Allo-MHC Restriction

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

Benefits of Targeting Both Pericytes and Endothelial Cells in the Tumor Vasculature With Kinase Inhibitors

Journal of Clinical Investigation
Medicine
2003English

Molecular Targeting of Liposomal Nanoparticles to Tumor Microenvironment

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2012English

CK2 Molecular Targeting—Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2017English

Immunomodulation of Breast Cancer via Tumor Antigen Specific Th1

Cancer Research and Treatment
Cancer ResearchOncology
2009English

Targeting Proliferating Tumor Cells via the Transcriptional Control of Therapeutic Genes

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2005English

Therapeutic Targeting of Tumor Associated Macrophages.

English

Mesenchymal Stem Cells and Cancer: Tumor-Specific Delivery Vehicles or Therapeutic Targets?

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy